Immunomodulation during sepsis in organ transplanted children

Area of Science:

• Immunology
• Transplantation
• Critical Care Medicine

Background:

• Immunosuppressive agents reduce acute graft rejection but increase post-transplant infections.
• Sepsis is a major cause of early and late mortality in organ transplant recipients.
• Sepsis involves excessive inflammation and impaired cell-mediated immunity, further complicated by immunosuppression.

Purpose of the Study:

• To review the impact of immunosuppressive agents and sepsis on cell-mediated immunity.
• To outline potential immunomodulatory treatments for sepsis in transplanted patients.

Main Methods:

• Literature review focusing on immunosuppression, sepsis, and cell-mediated immunity.
• Discussion of immunomodulatory strategies applied to non-transplanted septic patients.
• Exploration of speculative immunomodulation for sepsis in pediatric organ transplant recipients.

Main Results:

• Immunosuppression complicates the immune response during sepsis in transplant patients.
• Several immunomodulatory approaches show promise but lack clinical data in transplanted populations.

Conclusions:

• Immunomodulation strategies for sepsis in transplanted children are largely speculative.
• Further research is needed to validate immunomodulatory treatments in this vulnerable patient group.